143 related articles for article (PubMed ID: 19041054)
41. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
Deeg HJ; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski JL; Territo M; Ramsay N; Harris RE; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
Biol Blood Marrow Transplant; 1999; 5(4):243-52. PubMed ID: 10465104
[TBL] [Abstract][Full Text] [Related]
42. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
[No Abstract] [Full Text] [Related]
43. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
44. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
Passweg JR; Schanz U; Chalandon Y; Güngör T; Baldomero H; Heim D; Nair G; Medinger M; Masouridi-Levrat S; de Faveri GN; Tiercy JM;
Bone Marrow Transplant; 2015 Sep; 50(9):1201-5. PubMed ID: 26052916
[TBL] [Abstract][Full Text] [Related]
45. Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Arcuri LJ; Aguiar MTM; Ribeiro AAF; Pacheco AGF
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2422-2430. PubMed ID: 31386903
[TBL] [Abstract][Full Text] [Related]
46. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
47. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
[TBL] [Abstract][Full Text] [Related]
48. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.
Passweg JR; Pérez WS; Eapen M; Camitta BM; Gluckman E; Hinterberger W; Hows JM; Marsh JC; Pasquini R; Schrezenmeier H; Socié G; Zhang MJ; Bredeson C
Bone Marrow Transplant; 2006 Apr; 37(7):641-9. PubMed ID: 16489361
[TBL] [Abstract][Full Text] [Related]
49. HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.
Duquesnoy R; Spellman S; Haagenson M; Wang T; Horowitz MM; Oudshoorn M
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1064-1071. PubMed ID: 18721770
[TBL] [Abstract][Full Text] [Related]
50. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.
Giralt S; Logan B; Rizzo D; Zhang MJ; Ballen K; Emmanouilides C; Nath R; Parker P; Porter D; Sandmaier B; Waller EK; Barker J; Pavletic S; Weisdorf D
Biol Blood Marrow Transplant; 2007 Jul; 13(7):844-52. PubMed ID: 17580263
[TBL] [Abstract][Full Text] [Related]
51. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
[TBL] [Abstract][Full Text] [Related]
52. Unrelated donor marrow transplantation in children.
Balduzzi A; Gooley T; Anasetti C; Sanders JE; Martin PJ; Petersdorf EW; Appelbaum FR; Buckner CD; Matthews D; Storb R; Sullivan KM; Hansen JA
Blood; 1995 Oct; 86(8):3247-56. PubMed ID: 7579422
[TBL] [Abstract][Full Text] [Related]
53. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.
Wade JA; Hurley CK; Takemoto SK; Thompson J; Davies SM; Fuller TC; Rodey G; Confer DL; Noreen H; Haagenson M; Kan F; Klein J; Eapen M; Spellman S; Kollman C
Blood; 2007 May; 109(9):4064-70. PubMed ID: 17202313
[TBL] [Abstract][Full Text] [Related]
54. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
55. Unrelated donor bone marrow transplantation for hematological malignancies-current status.
Davies SM; Wagner JE; Weisdorf DJ; Shu XO; Blazar BR; Enright H; McGlave PB; Ramsay NK
Leuk Lymphoma; 1996 Oct; 23(3-4):221-6. PubMed ID: 9031102
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow transplantation for severe aplastic anemia in children.
Casper JT; Truitt RR; Baxter-Lowe LA; Ash RC
Am J Pediatr Hematol Oncol; 1990; 12(4):434-48. PubMed ID: 2285124
[TBL] [Abstract][Full Text] [Related]
57. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Martin PJ; Rowley SD; Anasetti C; Chauncey TR; Gooley T; Petersdorf EW; van Burik JA; Flowers ME; Storb R; Appelbaum FR; Hansen JA
Blood; 1999 Oct; 94(7):2192-9. PubMed ID: 10498588
[TBL] [Abstract][Full Text] [Related]
58. Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.
Pidala J; Kim J; Schell M; Lee SJ; Hillgruber R; Nye V; Ayala E; Alsina M; Betts B; Bookout R; Fernandez HF; Field T; Locke FL; Nishihori T; Ochoa JL; Perez L; Perkins J; Shapiro J; Tate C; Tomblyn M; Anasetti C
Bone Marrow Transplant; 2013 Mar; 48(3):346-50. PubMed ID: 22863723
[TBL] [Abstract][Full Text] [Related]
59. Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia.
Maury S; Balère-Appert ML; Pollichieni S; Oneto R; Yakoub-Agha I; Locatelli F; Dalle JH; Lanino E; Fischer A; Pession A; Huynh A; Barberi W; Mohty M; Risitano A; Milpied N; Socié G; Bacigalupo A; Marsh J; Passweg JR;
Am J Hematol; 2013 Oct; 88(10):868-73. PubMed ID: 23804195
[TBL] [Abstract][Full Text] [Related]
60. HLA typing and haematopoietic stem cell transplantation in the histocompatibility unit of the Ibn Sina University Hospital in Rabat (Morocco).
Brick C; Atouf O; Ouadghiri S; Drissi Bourhanbour A; Bougar S; Yakhlef I; Essakalli M
Transfus Clin Biol; 2019 Nov; 26(4):293-298. PubMed ID: 30366818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
